With cutaneous T-cell lymphoma (CTCL) being a rare disease with an incredibly high prevalence, Pierluigi Porcu, MD, from Sidney Kimmel Cancer Center, Philadelphia, PA, describes the challenges of CTCL at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX. Dr Porcu explains how treatment for CTCL patients is subject to the opinion of physicians, for example, dermatologists and medical oncologists may not agree in treatment choices. Dr Porcu also discusses the need for methods that can determine whether an individuals disease will progress or remain in the early stages.
Challenges in diagnosing and treating CTCL
